Featured
7.9 month improvement in metastatic bowel cancer patients following microsphere radiotherapy and chemotherapy – June 2, 2015
As published on Bowel Cancer Australia’s website today, results from an Australian-led global study have shown that treatment with radiation microspheres and chemotherapy (chemo-radiotherapy) improved progression-free survival in the liver by around eight months among metastatic bowel cancer patients. The SIRFLOX study – the world’s largest study of its kind involving 530 metastatic bowel cancer patients…
Read MoreProtecting your online self – A Guide to Social Media Afterlife: May 29, 2015
Palliative Care Australia’s (PCA) Guide to a Social Media Afterlife launched this week explains how to protect your online data after you pass away. When posting pictures, chatting on Facebook or issuing Tweets into cyberspace, probably the last thing on your mind is your mortality. More than 80 per cent of Aussies have done nothing…
Read MoreProtect against pneumococcal pneumonia – May 24, 2015
“Pneumococcal pneumonia is a severe lung infection caused by the bacterium Streptococcus pneumoniae, responsible for a large proportion of pneumonia cases among those aged 65 years and above” – A/Prof Lucy Morgan. According to Lung Foundation Australia’s ‘Lungs4Life’ research released this week, fewer than one-in-seven Australians (14 per cent) aged 18 to 74 who have…
Read MoreAbbott government committed to introducing new therapies to Australia – May 22, 2015
The Abbott Government has implemented more than 652 new and amended listings to the Pharmaceutical Benefits Scheme (PBS) since winning government in September, 2013. In a press conference held on Thursday, May 21, 2015, Federal Health Minister, The Hon. Sussan Ley MP, said “We are listing new and amended drugs, about 30 a month, which…
Read MoreBig pharma set for Senate tax avoidance inquiry investigation – May 22, 2015
Following an exposé of alleged “rampant off-shoring” of profits by tech-companies including Apple, Microsoft and Google, Australia’s Economics References Committee met last week to discuss widening the focus of its Senate Tax Avoidance Inquiry to include “big pharma”. The Senate Tax Avoidance Inquiry was referred to the Economics References Committee by Senate on October 2,…
Read More